Publicaciones en las que colabora con Celia Prior Darbonnens (13)

2017

  1. Strategies to design clinical studies to identify predictive biomarkers in cancer research

    Cancer Treatment Reviews, Vol. 53, pp. 79-97

2014

  1. Identification of tissue microRNAs predictive of sunitinib activity in patients with metastatic renal cell carcinoma

    PLoS ONE, Vol. 9, Núm. 1

  2. Synthesis and antiproliferative activity of novel selenoester derivatives

    European Journal of Medicinal Chemistry, Vol. 73, pp. 153-166

2012

  1. Residual dormant cancer stem-cell foci are responsible for tumor relapse after antiangiogenic metronomic therapy in hepatocellular carcinoma xenografts

    Laboratory Investigation, Vol. 92, Núm. 7, pp. 952-966

  2. The quinoline imidoselenocarbamate EI201 blocks the AKT/mTOR pathway and targets cancer stem cells leading to a strong antitumor activity

    Current Medicinal Chemistry, Vol. 19, Núm. 18, pp. 3031-3043

2011

  1. Phase II study of sunitinib as first-line treatment of urothelial cancer patients ineligible to receive cisplatin-based chemotherapy: Baseline interleukin-8 and tumor contrast enhancement as potential predictive factors of activity

    Annals of Oncology, Vol. 22, Núm. 12, pp. 2646-2653

  2. Synthesis and antiproliferative activity of novel symmetrical alkylthio- and alkylseleno-imidocarbamates

    European Journal of Medicinal Chemistry, Vol. 46, Núm. 1, pp. 265-274

  3. Therapeutic effect of lenalidomide in a novel xenograft mouse model of human blastic NK cell lymphoma/blastic plasmacytoid dendritic cell neoplasm

    Clinical Cancer Research, Vol. 17, Núm. 19, pp. 6163-6173

2010

  1. Use of a combination of biomarkers in serum and urine to improve detection of prostate cancer

    World Journal of Urology, Vol. 28, Núm. 6, pp. 681-686

2009

  1. Identification of TNF-α and MMP-9 as potential baseline predictive serum markers of sunitinib activity in patients with renal cell carcinoma using a human cytokine array

    British Journal of Cancer, Vol. 101, Núm. 11, pp. 1876-1883

  2. Synthesis and pharmacological screening of several aroyl and heteroaroyl selenylacetic acid derivatives as cytotoxic and antiproliferative agents

    Molecules, Vol. 14, Núm. 9, pp. 3313-3338

2008

  1. Phenotypic and genetic characterization of circulating tumor cells by combining immunomagnetic selection and FICTION techniques

    Journal of Histochemistry and Cytochemistry, Vol. 56, Núm. 7, pp. 667-675

2007

  1. Novel potent organoselenium compounds as cytotoxic agents in prostate cancer cells

    Bioorganic and Medicinal Chemistry Letters, Vol. 17, Núm. 24, pp. 6853-6859